Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Context Therapeutics Inc. (CNTX) had Return on Equity of -38.14% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-14.56M |
|
-- |
|
-- |
|
$14.97M |
|
$-14.97M |
|
$0.41M |
|
$-14.56M |
|
$-14.56M |
|
$-14.56M |
|
$-14.56M |
|
$-14.56M |
|
$-14.56M |
|
$-14.97M |
|
$-14.96M |
|
95.18M |
|
95.18M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$45.82M |
|
$0.07M |
|
$0.32M |
|
$46.13M |
|
$7.88M |
|
-- |
|
$0.08M |
|
$7.96M |
|
$38.17M |
|
$38.17M |
|
$38.17M |
|
91.88M |
|
| Cash Flow Statement Financials | |
$-18.45M |
|
$-4.56M |
|
-- |
|
$66.00M |
|
$42.99M |
|
$-23.00M |
|
$0.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-38.14% |
-38.14% |
|
-31.56% |
|
-38.14% |
|
$0.42 |
|
$-0.19 |
|
$-0.19 |
|